Biotech entity

SpaceX

Company

SpaceX is most often covered alongside Elon Musk, which appears in 1 of these 2 stories. That works out to roughly 1.8 stories per week across an 8-day span. Their average consequence score of 5 runs below the beat's 5.5 for that window.

Last mentioned: 8h ago

Entity pulse

Recent coverage · SpaceX

2 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about SpaceX

SpaceX is most often covered alongside Elon Musk, which appears in 1 of these 2 stories. That works out to roughly 1.8 stories per week across an 8-day span. Their average consequence score of 5 runs below the beat's 5.5 for that window. clinical-trial accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window. We currently track 2 Biotech stories that mention SpaceX, published between August 12, 2026 and August 19, 2026.

Stories tracked
2
Per week
1.8
Sources per story
2

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 40 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering SpaceX. Shared-story counts are live from our verified record — not editorial picks.

Key Data

ticker
SPCX
name
SpaceX
price
85.5
change
2.3
changePct
2.76

Stories mentioning SpaceX 2

Clinical Trials Neutral

Neuralink’s future in Musk’s $2.1T empire hinges on brain implant progress

While SpaceX’s record IPO captures headlines, Neuralink remains Musk’s most medically transformative—and least proven—venture. Brain-computer interface technology could revolutionize treatment for neurological disorders, but faces immense regulatory, clinical, and funding challenges. The empire’s financial coherence may dictate how fast this biotech moonshot advances.

2 sources

Source: economictimes.indiatimes.com · timesfreepress.com

SpaceX is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.